|
|
Congress Alerts
|
Clinical Spotlight from the 2011 Lung Cancer Conference in Amsterdam
|
|
 |
|
8 July 2011
|
| |
|
Emerging immunotherapies for non-small cell lung cancer (NSCLC)
This roundtable discussion between Nicholas Thatcher, MD, PhD, from The Christie Hospital in Manchester, United Kingdom, Suresh Ramalingam, MD, from Emory University, Atlanta, Georgia, United States, and Román Pérez-Soler, MD, from Montefiore Medical Center, Bronx, New York, United States, along with an eNewsflash and downloadable slides, covers the topic of emerging immunotherapies for non-small cell lung cancer (NSCLC), focusing on the following therapies:
- Talactoferrin
- Ipilimumab
- MAGE-A3 antigen-specific cancer immunotherapeutic (ASCI)
|
| |
|
|
| |
|
 View the Roundtable Discussion and access the downloadable slides
View eNewsflash |
|
|
|
|
|
|
